P0121 : Angiotensin II inhibition to treat severe liver fibrosis: A double-blind randomized trial (ANRS HC19)

P. Calès (1) , Y. Bacq , C. Bonny , J. L. Payen , D. Guyader (2, 3) , A. Tran (4) , D. Larrey , C. Silvain , M. C. Rousselet , M. Simony , F. Oberti , F Carrat (5, 6)

1 ICAT - SFR UA 4208 Interactions Cellulaires et Applications Thérapeutiques
2 Service des maladies du foie [CHU Rennes]
3 Foie, métabolismes et cancer
4 CHU Nice - Centre Hospitalier Universitaire de Nice
5 CHU Saint-Antoine [AP-HP]
6 DS3 - ESIM - Déterminants Sociaux de la Santé et du Recours aux Soins

no abstract

Domaines: Sciences du Vivant [q-bio]

P. Calès, Y. Bacq, C. Bonny, J. L. Payen, D. Guyader, et al.. P0121 : Angiotensin II inhibition to treat severe liver fibrosis: A double-blind randomized trial (ANRS HC19). The International Liver Congress™ 2015 – 50th Annual meeting of the European Association for the Study of the Liver, Apr 2015, Vienne, Austria. 62, Supplement 2, pp.S346, 2015, ⟨10.1016/S0168-8278(15)30341-X⟩. ⟨hal-01162771⟩